An essential trace element that serves as a cofactor for a small but critical family of enzymes — the molybdoenzymes — involved in purine catabolism, sulfite detoxification, and aldehyde metabolism [1]. Molybdenum appears in this wiki primarily through two findings: an inverse association with breast cancer risk in the largest prospective study of metals and breast cancer [2], and lower levels in PCOS patients in the first study to examine Mo in that condition [1]. Preterm mothers show reduced Mo status alongside other trace-element deficiencies, suggesting molybdenum adequacy may play a role in pregnancy outcomes (Al-Saleh et al. 2004; Hansen et al. 2017).
Chemical Properties
- Transition metal (Group 6); biologically active as Mo(IV), Mo(V), and Mo(VI).
- Functions exclusively as part of the molybdenum cofactor (Moco), a pterin-based organic molecule that coordinates Mo and inserts it into the active sites of molybdoenzymes.
- Moco deficiency is a rare but lethal inborn error of metabolism causing seizures, neurodegeneration, and early death.
- Dietary requirement is low: RDA of 45 ug/day for adults; UL of 2 mg/day.
Sources of Exposure
Dietary
- Legumes, grains, nuts, and leafy vegetables are the primary dietary sources.
- Soil molybdenum content varies geographically, affecting plant Mo concentrations.
- Baby food jars from Spain contained Mo at 4 times higher than maximum recommended values, alongside elevated manganese [3].
Key Molybdoenzymes
| Enzyme | Function | Clinical Relevance |
|---|---|---|
| Xanthine oxidase (XO) | Catalyzes hypoxanthine —> xanthine —> uric acid; generates superoxide and H2O2 as byproducts | Gout (uric acid accumulation); oxidative stress source; target of allopurinol |
| Sulfite oxidase | Oxidizes sulfite (SO3 2-) to sulfate (SO4 2-); detoxifies dietary and endogenous sulfite [1] | Sulfite sensitivity; isolated sulfite oxidase deficiency and Moco deficiency cause toxic sulfite accumulation, neurological damage, and early death (Schwarz et al. 2009) |
| Aldehyde oxidase | Oxidizes aromatic and aliphatic aldehydes; metabolizes drugs and xenobiotics | Drug metabolism (affects bioavailability of some pharmaceuticals) |
Xanthine oxidase is particularly relevant to this wiki because it is both a Mo-dependent enzyme and a significant endogenous source of ROS (superoxide and H2O2), connecting molybdenum status to oxidative stress [1].
Bacterial nitrate reductase and related Mo-dependent enzymes (formate dehydrogenase, DMSO reductase) enable anaerobic respiration in enteric pathogens such as E. coli and Salmonella. In the inflamed gut, host-derived nitrate from nitric oxide oxidation is exploited by Enterobacteriaceae via these Mo-dependent enzymes to outcompete obligate anaerobe commensals — a key mechanism of dysbiotic bloom (Winter et al. 2013; Lopez et al. 2015).
Health Effects
Breast Cancer -- Inverse Association
The Sister Study, the largest prospective study of metals and breast cancer (1,495 cases, 1,605 subcohort), found that Mo was the only metal with a significant inverse association with breast cancer risk [2]:
- Third tertile vs. first: HR = 0.82 (95% CI: 0.67, 1.00) for overall breast cancer.
- Stronger inverse association for ER-negative breast cancer (HR = 0.57, 95% CI: 0.38, 0.88).
- Toenail Mo reflects 6-12 months of exposure, providing longer-term assessment than blood/urine.
- Mechanism: potentially related to Mo's role as cofactor for enzymes that break down toxic sulfites and other xenobiotics [2].
PCOS -- Lower Levels
The first study to examine Mo in PCOS found significantly lower levels in affected women [1]:
- Mo whole blood: PCOS 0.60 vs control 0.71 ug/L (p = 0.024).
- Mo serum: PCOS 0.85 vs control 1.00 ug/L (p = 0.011).
- Negative correlation between Mo and LH levels in PCOS women, suggesting a potential protective role of Mo in reducing androgen levels.
- Differences were no longer statistically significant after adjusting for age, BMI, and hematocrit, indicating possible confounding.
- Dietary predictors: cereals and boiled vegetables were important predictors of Mo levels; Cu-Mo antagonism (excess Cu decreases Mo absorption by forming non-absorbable Cu-Mo complexes in the GI tract) may be relevant given elevated copper in PCOS [1].
- Mo positively correlated with AST, ALT, and urinary urobilinogen in PCOS, suggesting associations with liver function [1].
Kidney Function
- Included in multi-element urinary panels assessing associations between trace elements and kidney function [4].
Arthritis
- Included in machine learning analyses of heavy metal associations with arthritis [5].
Infant Overexposure
- Baby food jars showed Mo at 4x recommended values, raising concern about infant exposure [3].
Interactions with Other Metals
- Copper-molybdenum antagonism: Excess Cu decreases Mo absorption by forming insoluble Cu-Mo-S complexes (thiomolybdates) in the GI tract. This is well established in ruminant nutrition ("swayback" in sheep from Cu deficiency induced by high-Mo pastures) and may be relevant in human PCOS where Cu is elevated and Mo is low [1].
- Iron: Mo and Fe share some transport pathways; Moco synthesis requires iron-sulfur cluster biogenesis.
- Mo is classified as a toxic element in some food safety contexts (baby food studies) despite being essential [3].
Connections
- breast cancer — only metal inversely associated with risk in the Sister Study; stronger for ER-negative
- pcos — lower Mo in PCOS patients; Cu-Mo antagonism potentially relevant
- copper — antagonistic relationship; elevated Cu may drive low Mo in PCOS
- oxidative stress — xanthine oxidase (Mo-dependent) is a significant endogenous ROS source
- — Mo-dependent enzyme; target of gout therapy (allopurinol)
- — Mo overexposure in baby food jars
- iron — shared biosynthetic pathways for cofactor assembly